Monthly
US$200
Billed every month
Tranexamic Acid Injection(氨甲环酸注射液)
Companies, stages and changes, with each record available on this page.
Last 90 days: Accepted: 3 applications
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Company names, approval identifiers and strengths are retained as recorded in the Chinese sources. Category labels include the original wording for verification.
Catalogue holders33View records ↓
Under-review filings11View records ↓
This year’s generic filers3View records ↓
NHSA approval numbers106View records ↓
API companies with A status15View records ↓
Chemical-drug catalogue
Loaded records: 33 holders; 13 in the quality-and-efficacy consistency-evaluation category, and 20 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| 海南爱科制药有限公司 | 海南爱科制药有限公司 | 国药准字H20263462 | 2026/02/25 | 5ml:0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 海南爱科制药有限公司 | 海南爱科制药有限公司 | 国药准字H20263461 | 2026/02/25 | 5ml:0.25g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江兄弟药业有限公司 | 无锡凯夫制药有限公司 | 国药准字H20255800 | 2025/10/28 | 5ml∶0.25g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 上海信谊金朱药业有限公司 | 上海信谊金朱药业有限公司 | 国药准字H31021856 | 2025/07/15 | 5ml：0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 天方药业有限公司 | 天方药业有限公司 | 国药准字H20258023 | 2025/03/05 | 5ml：0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 广州泽盛药业科技有限公司 | 山东辉成药业有限公司 | 国药准字H20249632 | 2024/12/01 | 10ml:1.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 广州泽盛药业科技有限公司 | 山东辉成药业有限公司 | 国药准字H20249631 | 2024/12/01 | 5ml:0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 广州泽盛药业科技有限公司 | 山东辉成药业有限公司 | 国药准字H20249630 | 2024/12/01 | 5ml:0.25g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 西安汉丰药业有限责任公司 | 西安汉丰药业有限责任公司 | 国药准字H20244681 | 2024/08/20 | 5ml:0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 西安汉丰药业有限责任公司 | 西安汉丰药业有限责任公司 | 国药准字H20244682 | 2024/08/20 | 5ml:0.25g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 西安汉丰药业有限责任公司 | 西安汉丰药业有限责任公司 | 国药准字H20244683 | 2024/08/20 | 2.5ml:0.25g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 河南润弘制药股份有限公司 | 河南润弘制药股份有限公司 | 国药准字H20244340 | 2024/06/28 | 10ml：1.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 云南药科院生物医药股份有限公司 | 楚雄和创药业有限责任公司 | 国药准字H20244247 | 2024/06/28 | 10ml：1.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 河南润弘制药股份有限公司 | 河南润弘制药股份有限公司 | 国药准字H20244339 | 2024/06/28 | 5ml：0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 云南药科院生物医药股份有限公司 | 楚雄和创药业有限责任公司 | 国药准字H20244245 | 2024/06/28 | 5ml：0.25g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 云南药科院生物医药股份有限公司 | 楚雄和创药业有限责任公司 | 国药准字H20244246 | 2024/06/28 | 5ml：0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 烟台鲁银药业有限公司 | 烟台鲁银药业有限公司 | 国药准字H20243925 | 2024/06/04 | 10ml：1.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 烟台鲁银药业有限公司 | 烟台鲁银药业有限公司 | 国药准字H20243924 | 2024/06/04 | 5ml：0.25g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 华夏生生药业（北京）有限公司 | 华夏生生药业（北京）有限公司 | 国药准字H20243391 | 2024/03/29 | 10ml∶1g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 华夏生生药业（北京）有限公司 | 华夏生生药业（北京）有限公司 | 国药准字H20243390 | 2024/03/29 | 5ml∶0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 上海现代哈森（商丘）药业有限公司 | 上海现代哈森（商丘）药业有限公司 | 国药准字H20247042 | 2024/03/07 | 5ml︰0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 上海现代哈森（商丘）药业有限公司 | 上海现代哈森（商丘）药业有限公司 | 国药准字H20184047 | 2024/03/07 | 5ml︰0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 江西赣南海欣药业股份有限公司 | 江西赣南海欣药业股份有限公司 | 国药准字H20054443 | 2023/12/18 | 5ml：0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 湖北多瑞药业有限公司 | 湖北津药药业股份有限公司 | 国药准字H20234485 | 2023/11/14 | 10ml:1.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 吉林四长制药有限公司 | 吉林四长制药有限公司 | 国药准字H20233661 | 2023/06/07 | 5ml:0.25g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 嘉实（湖南）医药科技有限公司 | 湖南五洲通药业股份有限公司 | 国药准字H20233686 | 2023/06/07 | 5ml:0.25g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 嘉实（湖南）医药科技有限公司 | 湖南五洲通药业股份有限公司 | 国药准字H20233685 | 2023/06/07 | 2.5ml:0.25g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 贵州圣济堂制药有限公司 | 贵州圣济堂制药有限公司 | 国药准字H20063068 | 2023/04/05 | 5ml︰0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 锦州奥鸿药业有限责任公司 | 锦州奥鸿药业有限责任公司 | 国药准字H20233424 | 2023/04/04 | 2.5ml:0.25g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 锦州奥鸿药业有限责任公司 | 锦州奥鸿药业有限责任公司 | 国药准字H20233423 | 2023/04/04 | 10ml：1.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 蓬莱诺康药业有限公司 | 蓬莱诺康药业有限公司 | 国药准字H20233112 | 2023/01/31 | 5ml:0.25g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 蓬莱诺康药业有限公司 | 蓬莱诺康药业有限公司 | 国药准字H20233113 | 2023/01/31 | 10ml:1.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 成都第一制药有限公司 | 成都第一制药有限公司 | 国药准字H51021962 | 2023/01/18 | 5ml︰0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 成都第一制药有限公司 | 成都第一制药有限公司 | 国药准字H51021961 | 2023/01/18 | 5ml︰0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 广州绿十字制药股份有限公司 | 成都天台山制药有限公司 | 国药准字H20223969 | 2022/12/30 | 2.5ml：0.25g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 广州一品红制药有限公司 | 成都百裕制药股份有限公司 | 国药准字H20223955 | 2022/12/30 | 5ml : 0.25g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 湖北神州华瑞医药有限公司 | 山西诺成制药有限公司 | 国药准字H20223836 | 2022/11/08 | 5mL：0.25g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 知和（山东）大药厂有限公司 | 成都市海通药业有限公司 | 国药准字H20223839 | 2022/11/08 | 2.5ml:0.25g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 广东星昊药业有限公司 | 广东星昊药业有限公司 | 国药准字H20223764 | 2022/10/25 | 5ml:0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 广东星昊药业有限公司 | 广东星昊药业有限公司 | 国药准字H20223765 | 2022/10/25 | 10ml:1.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 重庆莱美药业股份有限公司 | 重庆莱美药业股份有限公司 | 国药准字H20056600 | 2022/08/23 | 5ml：0.25g | Not stated by source | CDE |
| 重庆莱美药业股份有限公司 | 重庆莱美药业股份有限公司 | 国药准字H20056601 | 2022/08/23 | 5ml：0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 湖南洞庭药业股份有限公司 | 湖南洞庭药业股份有限公司 | 国药准字H43020565 | 2022/07/22 | 5ml：0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 湖南洞庭药业股份有限公司 | 湖南洞庭药业股份有限公司 | 国药准字H20103730 | 2022/07/22 | 10ml：1.0g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 成都倍特药业股份有限公司 | 成都倍特药业股份有限公司 | 国药准字H20223389 | 2022/06/16 | 10ml:1.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 成都倍特药业股份有限公司 | 成都倍特药业股份有限公司 | 国药准字H20223388 | 2022/06/16 | 5ml:0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 成都倍特药业股份有限公司 | 成都倍特药业股份有限公司 | 国药准字H20223387 | 2022/06/16 | 5ml:0.25g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 成都利尔药业有限公司 | 成都利尔药业有限公司 | 国药准字H20227070 | 2022/05/23 | 2.5ml:0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 成都利尔药业有限公司 | 成都利尔药业有限公司 | 国药准字H20227069 | 2022/05/23 | 10ml:1.0g | Other drug (其他药品) | CDE |
| 湖南赛隆药业有限公司 | 湖南赛隆药业有限公司 | 国药准字H20183507 | 2022/03/02 | 5ml：0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 湖南赛隆药业有限公司 | 湖南赛隆药业有限公司 | 国药准字H20227024 | 2022/03/02 | 5ml：0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 扬子江药业集团南京海陵药业有限公司 | 扬子江药业集团南京海陵药业有限公司 | 国药准字H20123003 | 2022/02/18 | 5ml：0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 山西普德药业有限公司 | 山西普德药业有限公司 | 国药准字H14020887 | 2022/01/18 | 5ml：0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 山西普德药业有限公司 | 山西普德药业有限公司 | 国药准字H20227006 | 2022/01/18 | 10ml：1.0g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 成都利尔药业有限公司 | 成都利尔药业有限公司 | 国药准字H20093558 | 2021/04/21 | 5ml：0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 成都利尔药业有限公司 | 成都利尔药业有限公司 | 国药准字H20093557 | 2021/04/21 | 5ml：0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 瑞阳制药股份有限公司 | 瑞阳制药股份有限公司 | 国药准字H37021992 | 2021/04/21 | 5ml：0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 山西普德药业有限公司 | 山西普德药业有限公司 | 国药准字H14020888 | 2021/01/18 | 5ml：0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 成都市海通药业有限公司 | 成都市海通药业有限公司 | 国药准字H20234559 | 2023/11/28 | 5ml:0.25g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 106 distinct approval numbers and 54 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| 广东星昊药业有限公司 | 国药准字H20198009 | 2ml:0.2g | Category A (甲) | XB02AAA172B002010100198 | NHSA |
| 广州白云山天心制药股份有限公司 | 国药准字H20056987 | 10ml:1.0g | Category A (甲) | XB02AAA172B002010100377 | NHSA |
| 上海信谊金朱药业有限公司 | 国药准字H31021856 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010100801 | NHSA |
| 西南药业股份有限公司 | 国药准字H50020127 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010100978 | NHSA |
| 重庆莱美药业股份有限公司 | 国药准字H20056600 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010101017 | NHSA |
| 丹东医创药业有限责任公司 | 国药准字H21023554 | 2ml:0.1g | Category A (甲) | XB02AAA172B002010101157 | NHSA |
| 锦州奥鸿药业有限责任公司 | 国药准字H20233423 | 10ml:1.0g | Category A (甲) | XB02AAA172B002010101190 | NHSA |
| 常州兰陵制药有限公司 | 国药准字H32022034 | 2ml:0.1g | Category A (甲) | XB02AAA172B002010101376 | NHSA |
| 扬子江药业集团南京海陵药业有限公司 | 国药准字H20123004 | 5ml:0.5g | Category A (甲) | XB02AAA172B002010101748 | NHSA |
| 湖北津药药业股份有限公司 | 国药准字H20057476 | 10ml:1.0g | Category A (甲) | XB02AAA172B002010101866 | NHSA |
| 湖北美林药业有限公司 | 国药准字H42021043 | 2ml:0.1g | Category A (甲) | XB02AAA172B002010101869 | NHSA |
| 武汉爱民制药股份有限公司 | 国药准字H42021824 | 2ml:0.1g | Category A (甲) | XB02AAA172B002010101924 | NHSA |
| 宜昌人福药业有限责任公司 | 国药准字H20057547 | 2ml:0.25g | Category A (甲) | XB02AAA172B002010102000 | NHSA |
| 成都倍特药业股份有限公司 | 国药准字H20223387 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010102013 | NHSA |
| 四川奥邦古得药业有限公司 | 国药准字H20227070 | 2.5ml:0.25g | Category A (甲) | XB02AAA172B002010102044 | NHSA |
| 成都第一制药有限公司 | 国药准字H51021959 | 2ml:0.1g | Category A (甲) | XB02AAA172B002010102065 | NHSA |
| 广州绿十字制药股份有限公司 | 国药准字H20223969 | 2.5ml:0.25g | Category A (甲) | XB02AAA172B002010102066 | NHSA |
| 知和(山东)大药厂有限公司 | 国药准字H20223839 | 2.5ml:0.25g | Category A (甲) | XB02AAA172B002010102068 | NHSA |
| 成都利尔药业有限公司 | 国药准字H20093557 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010102118 | NHSA |
| 西安汉丰药业有限责任公司 | 国药准字H20244681 | 5ml:0.5g | Category A (甲) | XB02AAA172B002010102482 | NHSA |
| 河北美图制药有限责任公司 | 国药准字H13021933 | 2ml:0.1g | Category A (甲) | XB02AAA172B002010102598 | NHSA |
| 乐信乐美(海南)生物科技有限公司 | 国药准字H14020886 | 2ml:0.2g | Category A (甲) | XB02AAA172B002010102918 | NHSA |
| 开封制药(集团)有限公司 | 国药准字H20068120 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010103010 | NHSA |
| 河南辅仁怀庆堂制药有限公司 | 国药准字H41025296 | 2ml:0.1g | Category A (甲) | XB02AAA172B002010103021 | NHSA |
| 天方药业有限公司 | 国药准字H41021568 | 2ml:0.1g | Category A (甲) | XB02AAA172B002010103098 | NHSA |
| 上海现代哈森(商丘)药业有限公司 | 国药准字H20184047 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010103202 | NHSA |
| 河南润弘制药股份有限公司 | 国药准字H20244339 | 5ml:0.5g | Category A (甲) | XB02AAA172B002010103257 | NHSA |
| 吉林四长制药有限公司 | 国药准字H20233661 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010103282 | NHSA |
| 黑龙江省格润药业有限责任公司 | 国药准字H23022174 | 2ml:0.1g | Category A (甲) | XB02AAA172B002010103820 | NHSA |
| 华润双鹤利民药业(济南)有限公司 | 国药准字H20103542 | 10ml:1g | Category A (甲) | XB02AAA172B002010103973 | NHSA |
| 远大生命科学(山东)有限公司 | 国药准字H20233112 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010104017 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20163442 | 2ml:0.1g | Category A (甲) | XB02AAA172B002010104145 | NHSA |
| 瑞阳制药股份有限公司 | 国药准字H37021993 | 2ml:0.1g | Category A (甲) | XB02AAA172B002010104152 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20243924 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010104240 | NHSA |
| 浙江诚意药业股份有限公司 | 国药准字H33021422 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010104615 | NHSA |
| 福州海王福药制药有限公司 | 国药准字H20059505 | 10ml:1g | Category A (甲) | XB02AAA172B002010104827 | NHSA |
| 湖南洞庭药业股份有限公司 | 国药准字H20103730 | 10ml:1.0g | Category A (甲) | XB02AAA172B002010104917 | NHSA |
| 紫光古汉集团衡阳制药有限公司 | 国药准字H43021272 | 5ml:0.5g | Category A (甲) | XB02AAA172B002010105019 | NHSA |
| 江西赣南海欣药业股份有限公司 | 国药准字H20054442 | 2ml:0.2g | Category A (甲) | XB02AAA172B002010105283 | NHSA |
| 贵州圣济堂制药有限公司 | 国药准字H20063068 | 5ml:0.5g | Category A (甲) | XB02AAA172B002010105521 | NHSA |
| 湖北神州华瑞医药有限公司 | 国药准字H20223836 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010105619 | NHSA |
| 海南通用康力制药有限公司 | 国药准字H20053568 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010105754 | NHSA |
| 海南爱科制药有限公司 | 国药准字H20263461 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010105759 | NHSA |
| 湖北多瑞药业有限公司 | 国药准字H20234485 | 10ml:1.0g | Category A (甲) | XB02AAA172B002010106652 | NHSA |
| 广州一品红制药有限公司 | 国药准字H20223955 | 5ml : 0.25g | Category A (甲) | XB02AAA172B002010106725 | NHSA |
| 华夏生生药业(北京)有限公司 | 国药准字H20243390 | 5ml:0.5g | Category A (甲) | XB02AAA172B002010109910 | NHSA |
| 湖南赛隆药业有限公司 | 国药准字H20183507 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010179286 | NHSA |
| 海南金瑞宝医药科技有限公司 | 国药准字H20233685 | 2.5ml:0.25g | Category A (甲) | XB02AAA172B002010183048 | NHSA |
| 浙江兄弟药业有限公司 | 国药准字H20255800 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010183781 | NHSA |
| 云南药科院生物医药股份有限公司 | 国药准字H20244246 | 5ml:0.5g | Category A (甲) | XB02AAA172B002010184547 | NHSA |
| 广州泽盛药业科技有限公司 | 国药准字H20249630 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010184776 | NHSA |
| 广东星昊药业有限公司 | 国药准字H20198009 | 2ml:0.2g | Category A (甲) | XB02AAA172B002010200198 | NHSA |
| 广州白云山天心制药股份有限公司 | 国药准字H20056987 | 10ml:1.0g | Category A (甲) | XB02AAA172B002010200377 | NHSA |
| 上海信谊金朱药业有限公司 | 国药准字H31021856 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010200801 | NHSA |
| 西南药业股份有限公司 | 国药准字H50020127 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010200978 | NHSA |
| 重庆莱美药业股份有限公司 | 国药准字H20056600 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010201017 | NHSA |
| 锦州奥鸿药业有限责任公司 | 国药准字H20233423 | 10ml:1.0g | Category A (甲) | XB02AAA172B002010201190 | NHSA |
| 常州兰陵制药有限公司 | 国药准字H32022034 | 2ml:0.1g | Category A (甲) | XB02AAA172B002010201376 | NHSA |
| 扬子江药业集团南京海陵药业有限公司 | 国药准字H20123004 | 5ml:0.5g | Category A (甲) | XB02AAA172B002010201748 | NHSA |
| 湖北津药药业股份有限公司 | 国药准字H20057476 | 10ml:1.0g | Category A (甲) | XB02AAA172B002010201866 | NHSA |
| 湖北美林药业有限公司 | 国药准字H42021043 | 2ml:0.1g | Category A (甲) | XB02AAA172B002010201869 | NHSA |
| 武汉爱民制药股份有限公司 | 国药准字H42021824 | 2ml:0.1g | Category A (甲) | XB02AAA172B002010201924 | NHSA |
| 成都倍特药业股份有限公司 | 国药准字H20223388 | 5ml:0.5g | Category A (甲) | XB02AAA172B002010202013 | NHSA |
| 四川奥邦古得药业有限公司 | 国药准字H20227070 | 2.5ml:0.25g | Category A (甲) | XB02AAA172B002010202044 | NHSA |
| 成都第一制药有限公司 | 国药准字H51021960 | 2ml:0.2g | Category A (甲) | XB02AAA172B002010202065 | NHSA |
| 广州绿十字制药股份有限公司 | 国药准字H20223969 | 2.5ml:0.25g | Category A (甲) | XB02AAA172B002010202066 | NHSA |
| 知和(山东)大药厂有限公司 | 国药准字H20223839 | 2.5ml:0.25g | Category A (甲) | XB02AAA172B002010202068 | NHSA |
| 成都利尔药业有限公司 | 国药准字H20093558 | 5ml:0.5g | Category A (甲) | XB02AAA172B002010202118 | NHSA |
| 西安汉丰药业有限责任公司 | 国药准字H20244681 | 5ml:0.5g | Category A (甲) | XB02AAA172B002010202482 | NHSA |
| 乐信乐美(海南)生物科技有限公司 | 国药准字H14020886 | 2ml:0.2g | Category A (甲) | XB02AAA172B002010202918 | NHSA |
| 开封制药(集团)有限公司 | 国药准字H20068120 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010203010 | NHSA |
| 天方药业有限公司 | 国药准字H41021568 | 2ml:0.1g | Category A (甲) | XB02AAA172B002010203098 | NHSA |
| 上海现代哈森(商丘)药业有限公司 | 国药准字H20184047 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010203202 | NHSA |
| 吉林四长制药有限公司 | 国药准字H20233661 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010203282 | NHSA |
| 华润双鹤利民药业(济南)有限公司 | 国药准字H20103542 | 10ml:1g | Category A (甲) | XB02AAA172B002010203973 | NHSA |
| 远大生命科学(山东)有限公司 | 国药准字H20233112 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010204017 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20163442 | 2ml:0.1g | Category A (甲) | XB02AAA172B002010204145 | NHSA |
| 瑞阳制药股份有限公司 | 国药准字H37021993 | 2ml:0.1g | Category A (甲) | XB02AAA172B002010204152 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20243924 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010204240 | NHSA |
| 福州海王福药制药有限公司 | 国药准字H20059505 | 10ml:1g | Category A (甲) | XB02AAA172B002010204827 | NHSA |
| 湖南洞庭药业股份有限公司 | 国药准字H20103730 | 10ml:1.0g | Category A (甲) | XB02AAA172B002010204917 | NHSA |
| 江西赣南海欣药业股份有限公司 | 国药准字H20054442 | 2ml:0.2g | Category A (甲) | XB02AAA172B002010205283 | NHSA |
| 贵州圣济堂制药有限公司 | 国药准字H20063068 | 5ml:0.5g | Category A (甲) | XB02AAA172B002010205521 | NHSA |
| 湖北神州华瑞医药有限公司 | 国药准字H20223836 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010205619 | NHSA |
| 海南通用康力制药有限公司 | 国药准字H20053568 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010205754 | NHSA |
| 湖北多瑞药业有限公司 | 国药准字H20234485 | 10ml:1.0g | Category A (甲) | XB02AAA172B002010206652 | NHSA |
| 广州一品红制药有限公司 | 国药准字H20223955 | 5ml : 0.25g | Category A (甲) | XB02AAA172B002010206725 | NHSA |
| 华夏生生药业(北京)有限公司 | 国药准字H20243390 | 5ml:0.5g | Category A (甲) | XB02AAA172B002010209910 | NHSA |
| 湖南赛隆药业有限公司 | 国药准字H20183507 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010279286 | NHSA |
| 云南药科院生物医药股份有限公司 | 国药准字H20244246 | 5ml:0.5g | Category A (甲) | XB02AAA172B002010284547 | NHSA |
| 重庆莱美药业股份有限公司 | 国药准字H20056600 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010301017 | NHSA |
| 江苏朗欧药业有限公司 | 国药准字H32022144 | 5ml:0.5g | Category A (甲) | XB02AAA172B002010301723 | NHSA |
| 扬子江药业集团南京海陵药业有限公司 | 国药准字H20123004 | 5ml:0.5g | Category A (甲) | XB02AAA172B002010301748 | NHSA |
| 成都倍特药业股份有限公司 | 国药准字H20223387 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010302013 | NHSA |
| 知和(山东)大药厂有限公司 | 国药准字H20223839 | 2.5ml:0.25g | Category A (甲) | XB02AAA172B002010302068 | NHSA |
| 成都利尔药业有限公司 | 国药准字H20093558 | 5ml:0.5g | Category A (甲) | XB02AAA172B002010302118 | NHSA |
| 天方药业有限公司 | 国药准字H41021568 | 2ml:0.1g | Category A (甲) | XB02AAA172B002010303098 | NHSA |
| 瑞阳制药股份有限公司 | 国药准字H37021993 | 2ml:0.1g | Category A (甲) | XB02AAA172B002010304152 | NHSA |
| 湖南洞庭药业股份有限公司 | 国药准字H20103730 | 10ml:1.0g | Category A (甲) | XB02AAA172B002010304917 | NHSA |
| 湖北神州华瑞医药有限公司 | 国药准字H20223836 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010305619 | NHSA |
| 海南通用康力制药有限公司 | 国药准字H20053568 | 5ml:0.25g | Category A (甲) | XB02AAA172B002010305754 | NHSA |
| 广州一品红制药有限公司 | 国药准字H20223955 | 5ml : 0.25g | Category A (甲) | XB02AAA172B002010306725 | NHSA |
| 江苏朗欧药业有限公司 | 国药准字H32022144 | 5ml:0.5g | Category A (甲) | XB02AAA172B002010401723 | NHSA |
| 成都倍特药业股份有限公司 | 国药准字H20223388 | 5ml:0.5g | Category A (甲) | XB02AAA172B002010402013 | NHSA |
| 广东星昊药业有限公司 | 国药准字H20223764 | 5ml:0.5g | Category A (甲) | XB02AAA172B002020100198 | NHSA |
| 广州白云山天心制药股份有限公司 | 国药准字H20056986 | 5ml:0.5g | Category A (甲) | XB02AAA172B002020100377 | NHSA |
| 西南药业股份有限公司 | 国药准字H50020115 | 2ml:0.1g | Category A (甲) | XB02AAA172B002020100978 | NHSA |
| 重庆莱美药业股份有限公司 | 国药准字H20056601 | 5ml:0.5g | Category A (甲) | XB02AAA172B002020101017 | NHSA |
| 丹东医创药业有限责任公司 | 国药准字H21020644 | 5ml:0.25g | Category A (甲) | XB02AAA172B002020101157 | NHSA |
| 锦州奥鸿药业有限责任公司 | 国药准字H20233424 | 2.5ml:0.25g | Category A (甲) | XB02AAA172B002020101190 | NHSA |
| 常州兰陵制药有限公司 | 国药准字H32022033 | 2ml:0.2g | Category A (甲) | XB02AAA172B002020101376 | NHSA |
| 扬子江药业集团南京海陵药业有限公司 | 国药准字H20123005 | 2ml:0.1g | Category A (甲) | XB02AAA172B002020101748 | NHSA |
| 湖北津药药业股份有限公司 | 国药准字H20057475 | 2ml:0.2g | Category A (甲) | XB02AAA172B002020101866 | NHSA |
| 湖北美林药业有限公司 | 国药准字H20044601 | 5ml:0.5g | Category A (甲) | XB02AAA172B002020101869 | NHSA |
| 武汉爱民制药股份有限公司 | 国药准字H42021825 | 5ml:0.25g | Category A (甲) | XB02AAA172B002020101924 | NHSA |
| 成都倍特药业股份有限公司 | 国药准字H20223389 | 10ml:1.0g | Category A (甲) | XB02AAA172B002020102013 | NHSA |
| 成都利尔药业有限公司 | 国药准字H20227069 | 10ml:1.0g | Category A (甲) | XB02AAA172B002020102044 | NHSA |
| 成都第一制药有限公司 | 国药准字H51021961 | 5ml:0.25g | Category A (甲) | XB02AAA172B002020102065 | NHSA |
| 成都市海通药业有限公司 | 国药准字H20234559 | 5ml:0.25g | Category A (甲) | XB02AAA172B002020102068 | NHSA |
| 成都利尔药业有限公司 | 国药准字H20093557 | 5ml:0.25g | Category A (甲) | XB02AAA172B002020102118 | NHSA |
| 西安汉丰药业有限责任公司 | 国药准字H20244682 | 5ml:0.25g | Category A (甲) | XB02AAA172B002020102482 | NHSA |
| 乐信乐美(海南)生物科技有限公司 | 国药准字H14020888 | 5ml:0.25g | Category A (甲) | XB02AAA172B002020102918 | NHSA |
| 河南辅仁怀庆堂制药有限公司 | 国药准字H41025296 | 2ml:0.1g | Category A (甲) | XB02AAA172B002020103021 | NHSA |
| 天方药业有限公司 | 国药准字H20258023 | 5ml:0.25g | Category A (甲) | XB02AAA172B002020103098 | NHSA |
| 上海现代哈森(商丘)药业有限公司 | 国药准字H20247042 | 5ml:0.5g | Category A (甲) | XB02AAA172B002020103202 | NHSA |
| 河南润弘制药股份有限公司 | 国药准字H20244340 | 10ml:1.0g | Category A (甲) | XB02AAA172B002020103257 | NHSA |
| 黑龙江省格润药业有限责任公司 | 国药准字H20058293 | 10ml:1g | Category A (甲) | XB02AAA172B002020103820 | NHSA |
| 华润双鹤利民药业(济南)有限公司 | 国药准字H20103541 | 5ml:0.5g | Category A (甲) | XB02AAA172B002020103973 | NHSA |
| 远大生命科学(山东)有限公司 | 国药准字H20233113 | 10ml:1.0g | Category A (甲) | XB02AAA172B002020104017 | NHSA |
| 瑞阳制药股份有限公司 | 国药准字H37021992 | 5ml:0.25g | Category A (甲) | XB02AAA172B002020104152 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20243925 | 10ml:1.0g | Category A (甲) | XB02AAA172B002020104240 | NHSA |
| 福州海王福药制药有限公司 | 国药准字H20059504 | 5ml:0.5g | Category A (甲) | XB02AAA172B002020104827 | NHSA |
| 湖南洞庭药业股份有限公司 | 国药准字H19994139 | 2ml:0.2g | Category A (甲) | XB02AAA172B002020104917 | NHSA |
| 江西赣南海欣药业股份有限公司 | 国药准字H20054443 | 5ml:0.5g | Category A (甲) | XB02AAA172B002020105283 | NHSA |
| 海南通用康力制药有限公司 | 国药准字H20053569 | 5ml:0.5g | Category A (甲) | XB02AAA172B002020105754 | NHSA |
| 海南爱科制药有限公司 | 国药准字H20263462 | 5ml:0.5g | Category A (甲) | XB02AAA172B002020105759 | NHSA |
| 华夏生生药业(北京)有限公司 | 国药准字H20243391 | 10ml:1g | Category A (甲) | XB02AAA172B002020109910 | NHSA |
| 湖南赛隆药业有限公司 | 国药准字H20227024 | 5ml:0.5g | Category A (甲) | XB02AAA172B002020179286 | NHSA |
| 海南金瑞宝医药科技有限公司 | 国药准字H20233686 | 5ml:0.25g | Category A (甲) | XB02AAA172B002020183048 | NHSA |
| 云南药科院生物医药股份有限公司 | 国药准字H20244247 | 10ml:1.0g | Category A (甲) | XB02AAA172B002020184547 | NHSA |
| 广州泽盛药业科技有限公司 | 国药准字H20249632 | 10ml:1.0g | Category A (甲) | XB02AAA172B002020184776 | NHSA |
| 广东星昊药业有限公司 | 国药准字H20223764 | 5ml:0.5g | Category A (甲) | XB02AAA172B002020200198 | NHSA |
| 广州白云山天心制药股份有限公司 | 国药准字H20056986 | 5ml:0.5g | Category A (甲) | XB02AAA172B002020200377 | NHSA |
| 西南药业股份有限公司 | 国药准字H50020115 | 2ml:0.1g | Category A (甲) | XB02AAA172B002020200978 | NHSA |
| 重庆莱美药业股份有限公司 | 国药准字H20056601 | 5ml:0.5g | Category A (甲) | XB02AAA172B002020201017 | NHSA |
| 丹东医创药业有限责任公司 | 国药准字H21020644 | 5ml:0.25g | Category A (甲) | XB02AAA172B002020201157 | NHSA |
| 锦州奥鸿药业有限责任公司 | 国药准字H20233424 | 2.5ml:0.25g | Category A (甲) | XB02AAA172B002020201190 | NHSA |
| 江苏朗欧药业有限公司 | 国药准字H20059851 | 10ml:1g | Category A (甲) | XB02AAA172B002020201723 | NHSA |
| 扬子江药业集团南京海陵药业有限公司 | 国药准字H20123006 | 2ml:0.2g | Category A (甲) | XB02AAA172B002020201748 | NHSA |
| 湖北津药药业股份有限公司 | 国药准字H20057475 | 2ml:0.2g | Category A (甲) | XB02AAA172B002020201866 | NHSA |
| 湖北美林药业有限公司 | 国药准字H20044601 | 5ml:0.5g | Category A (甲) | XB02AAA172B002020201869 | NHSA |
| 武汉爱民制药股份有限公司 | 国药准字H42021825 | 5ml:0.25g | Category A (甲) | XB02AAA172B002020201924 | NHSA |
| 成都倍特药业股份有限公司 | 国药准字H20223389 | 10ml:1.0g | Category A (甲) | XB02AAA172B002020202013 | NHSA |
| 成都利尔药业有限公司 | 国药准字H20227069 | 10ml:1.0g | Category A (甲) | XB02AAA172B002020202044 | NHSA |
| 成都第一制药有限公司 | 国药准字H51021962 | 5ml:0.5g | Category A (甲) | XB02AAA172B002020202065 | NHSA |
| 成都市海通药业有限公司 | 国药准字H20234559 | 5ml:0.25g | Category A (甲) | XB02AAA172B002020202068 | NHSA |
| 西安汉丰药业有限责任公司 | 国药准字H20244682 | 5ml:0.25g | Category A (甲) | XB02AAA172B002020202482 | NHSA |
| 乐信乐美(海南)生物科技有限公司 | 国药准字H14020888 | 5ml:0.25g | Category A (甲) | XB02AAA172B002020202918 | NHSA |
| 天方药业有限公司 | 国药准字H20258023 | 5ml:0.25g | Category A (甲) | XB02AAA172B002020203098 | NHSA |
| 黑龙江省格润药业有限责任公司 | 国药准字H20058293 | 10ml:1g | Category A (甲) | XB02AAA172B002020203820 | NHSA |
| 华润双鹤利民药业(济南)有限公司 | 国药准字H20103541 | 5ml:0.5g | Category A (甲) | XB02AAA172B002020203973 | NHSA |
| 远大生命科学(山东)有限公司 | 国药准字H20233113 | 10ml:1.0g | Category A (甲) | XB02AAA172B002020204017 | NHSA |
| 瑞阳制药股份有限公司 | 国药准字H37021992 | 5ml:0.25g | Category A (甲) | XB02AAA172B002020204152 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20243925 | 10ml:1.0g | Category A (甲) | XB02AAA172B002020204240 | NHSA |
| 福州海王福药制药有限公司 | 国药准字H20059504 | 5ml:0.5g | Category A (甲) | XB02AAA172B002020204827 | NHSA |
| 湖南洞庭药业股份有限公司 | 国药准字H19994139 | 2ml:0.2g | Category A (甲) | XB02AAA172B002020204917 | NHSA |
| 江西赣南海欣药业股份有限公司 | 国药准字H20054443 | 5ml:0.5g | Category A (甲) | XB02AAA172B002020205283 | NHSA |
| 海南通用康力制药有限公司 | 国药准字H20053569 | 5ml:0.5g | Category A (甲) | XB02AAA172B002020205754 | NHSA |
| 华夏生生药业(北京)有限公司 | 国药准字H20243391 | 10ml:1g | Category A (甲) | XB02AAA172B002020209910 | NHSA |
| 湖南赛隆药业有限公司 | 国药准字H20227024 | 5ml:0.5g | Category A (甲) | XB02AAA172B002020279286 | NHSA |
| 云南药科院生物医药股份有限公司 | 国药准字H20244247 | 10ml:1.0g | Category A (甲) | XB02AAA172B002020284547 | NHSA |
| 广州白云山天心制药股份有限公司 | 国药准字H20056986 | 5ml:0.5g | Category A (甲) | XB02AAA172B002020300377 | NHSA |
| 西南药业股份有限公司 | 国药准字H50020115 | 2ml:0.1g | Category A (甲) | XB02AAA172B002020300978 | NHSA |
| 重庆莱美药业股份有限公司 | 国药准字H20056601 | 5ml:0.5g | Category A (甲) | XB02AAA172B002020301017 | NHSA |
| 江苏朗欧药业有限公司 | 国药准字H20059851 | 10ml:1g | Category A (甲) | XB02AAA172B002020301723 | NHSA |
| 扬子江药业集团南京海陵药业有限公司 | 国药准字H20123005 | 2ml:0.1g | Category A (甲) | XB02AAA172B002020301748 | NHSA |
| 湖北美林药业有限公司 | 国药准字H20044601 | 5ml:0.5g | Category A (甲) | XB02AAA172B002020301869 | NHSA |
| 成都第一制药有限公司 | 国药准字H51021962 | 5ml:0.5g | Category A (甲) | XB02AAA172B002020302065 | NHSA |
| 成都市海通药业有限公司 | 国药准字H20234559 | 5ml:0.25g | Category A (甲) | XB02AAA172B002020302068 | NHSA |
| 瑞阳制药股份有限公司 | 国药准字H37021992 | 5ml:0.25g | Category A (甲) | XB02AAA172B002020304152 | NHSA |
| 扬子江药业集团南京海陵药业有限公司 | 国药准字H20123006 | 2ml:0.2g | Category A (甲) | XB02AAA172B002020401748 | NHSA |
| 广东星昊药业有限公司 | 国药准字H20223765 | 10ml:1.0g | Category A (甲) | XB02AAA172B002030100198 | NHSA |
| 重庆莱美药业股份有限公司 | 国药准字H20056600 | 5ml:0.25g | Category A (甲) | XB02AAA172B002030101017 | NHSA |
| 丹东医创药业有限责任公司 | 国药准字H21023554 | 2ml:0.1g | Category A (甲) | XB02AAA172B002030101157 | NHSA |
| 江苏朗欧药业有限公司 | 国药准字H32022145 | 2ml:0.1g | Category A (甲) | XB02AAA172B002030101723 | NHSA |
| 扬子江药业集团南京海陵药业有限公司 | 国药准字H20123003 | 5ml:0.25g | Category A (甲) | XB02AAA172B002030101748 | NHSA |
| 湖北美林药业有限公司 | 国药准字H20056277 | 10ml:1g | Category A (甲) | XB02AAA172B002030101869 | NHSA |
| 成都第一制药有限公司 | 国药准字H51021961 | 5ml:0.25g | Category A (甲) | XB02AAA172B002030102065 | NHSA |
| 西安汉丰药业有限责任公司 | 国药准字H20244683 | 2.5ml:0.25g | Category A (甲) | XB02AAA172B002030102482 | NHSA |
| 乐信乐美(海南)生物科技有限公司 | 国药准字H14020887 | 5ml:0.5g | Category A (甲) | XB02AAA172B002030102918 | NHSA |
| 黑龙江省格润药业有限责任公司 | 国药准字H23022173 | 5ml:0.25g | Category A (甲) | XB02AAA172B002030103820 | NHSA |
| 湖南洞庭药业股份有限公司 | 国药准字H43020565 | 5ml:0.5g | Category A (甲) | XB02AAA172B002030104917 | NHSA |
| 云南药科院生物医药股份有限公司 | 国药准字H20244245 | 5ml:0.25g | Category A (甲) | XB02AAA172B002030184547 | NHSA |
| 广州泽盛药业科技有限公司 | 国药准字H20249631 | 5ml:0.5g | Category A (甲) | XB02AAA172B002030184776 | NHSA |
| 广东星昊药业有限公司 | 国药准字H20223765 | 10ml:1.0g | Category A (甲) | XB02AAA172B002030200198 | NHSA |
| 重庆莱美药业股份有限公司 | 国药准字H20056601 | 5ml:0.5g | Category A (甲) | XB02AAA172B002030201017 | NHSA |
| 江苏朗欧药业有限公司 | 国药准字H32022142 | 2ml:0.2g | Category A (甲) | XB02AAA172B002030201723 | NHSA |
| 扬子江药业集团南京海陵药业有限公司 | 国药准字H20123003 | 5ml:0.25g | Category A (甲) | XB02AAA172B002030201748 | NHSA |
| 西安汉丰药业有限责任公司 | 国药准字H20244683 | 2.5ml:0.25g | Category A (甲) | XB02AAA172B002030202482 | NHSA |
| 乐信乐美(海南)生物科技有限公司 | 国药准字H14020887 | 5ml:0.5g | Category A (甲) | XB02AAA172B002030202918 | NHSA |
| 黑龙江省格润药业有限责任公司 | 国药准字H23022173 | 5ml:0.25g | Category A (甲) | XB02AAA172B002030203820 | NHSA |
| 湖南洞庭药业股份有限公司 | 国药准字H43020565 | 5ml:0.5g | Category A (甲) | XB02AAA172B002030204917 | NHSA |
| 云南药科院生物医药股份有限公司 | 国药准字H20244245 | 5ml:0.25g | Category A (甲) | XB02AAA172B002030284547 | NHSA |
| 江苏朗欧药业有限公司 | 国药准字H32022142 | 2ml:0.2g | Category A (甲) | XB02AAA172B002030301723 | NHSA |
| 扬子江药业集团南京海陵药业有限公司 | 国药准字H20123003 | 5ml:0.25g | Category A (甲) | XB02AAA172B002030301748 | NHSA |
| 江苏朗欧药业有限公司 | 国药准字H32022145 | 2ml:0.1g | Category A (甲) | XB02AAA172B002030401723 | NHSA |
| 扬子江药业集团南京海陵药业有限公司 | 国药准字H20123003 | 5ml:0.25g | Category A (甲) | XB02AAA172B002030401748 | NHSA |
| 常州兰陵制药有限公司 | 国药准字H32022033 | 2ml:0.2g | Category A (甲) | XB02AAA172B002040101376 | NHSA |
| 江苏朗欧药业有限公司 | 国药准字H32022143 | 5ml:0.25g | Category A (甲) | XB02AAA172B002040101723 | NHSA |
| 湖北美林药业有限公司 | 国药准字H20056277 | 10ml:1g | Category A (甲) | XB02AAA172B002040101869 | NHSA |
| 美享生物制药(珠海)有限公司 | 国药准字H20227006 | 10ml:1.0g | Category A (甲) | XB02AAA172B002040102918 | NHSA |
| 江苏朗欧药业有限公司 | 国药准字H32022143 | 5ml:0.25g | Category A (甲) | XB02AAA172B002040201723 | NHSA |
| 美享生物制药(珠海)有限公司 | 国药准字H20227006 | 10ml:1.0g | Category A (甲) | XB02AAA172B002040202918 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 11 filings and 7 distinct first applicants.
Generic 9 · Supplement 2
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 南京易腾药物研究院有限公司;金陵药业股份有限公司南京金陵制药厂 | CYHS2600239 | Generic | 2026/01/21 | Not stated by source | CDE |
| 湖南赛隆药业有限公司;湖南赛隆药业（长沙）有限公司 | CYHB2601801 | Supplement | 2026/09/23 | Not stated by source | CDE |
| 辰欣药业股份有限公司 | CYHS2602320 | Generic | 2026/09/17 | Not stated by source | CDE |
| 辰欣药业股份有限公司 | CYHS2602319 | Generic | 2026/09/17 | Not stated by source | CDE |
| 湖南先施制药有限公司 | CYHS2600390 | Generic | 2026/02/06 | Not stated by source | CDE |
| 湖南先施制药有限公司 | CYHS2600389 | Generic | 2026/02/06 | Not stated by source | CDE |
| 成都华宇制药有限公司 | CYHS2504082 | Generic | 2025/11/27 | Not stated by source | CDE |
| 山东益健药业有限公司 | CYHB2550338 | Supplement | 2025/10/14 | Not stated by source | CDE |
| 河南普瑞药业有限公司 | CYHS2502700 | Generic | 2025/07/25 | Not stated by source | CDE |
| 河南普瑞药业有限公司 | CYHS2502699 | Generic | 2025/07/25 | Not stated by source | CDE |
| 河南普瑞药业有限公司 | CYHS2502698 | Generic | 2025/07/25 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 5 filings and 3 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 南京易腾药物研究院有限公司;金陵药业股份有限公司南京金陵制药厂 | CYHS2600239 | Generic | 2026/01/21 | Not stated by source | CDE |
| 辰欣药业股份有限公司 | CYHS2602320 | Generic | 2026/09/17 | Not stated by source | CDE |
| 辰欣药业股份有限公司 | CYHS2602319 | Generic | 2026/09/17 | Not stated by source | CDE |
| 湖南先施制药有限公司 | CYHS2600390 | Generic | 2026/02/06 | Not stated by source | CDE |
| 湖南先施制药有限公司 | CYHS2600389 | Generic | 2026/02/06 | Not stated by source | CDE |
API registrations
Non-component matches: 15 companies with A status and 5 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 氨甲环酸 | 江苏天和制药股份有限公司 | Y20260000642 | I | Exact ingredient | 2026/08/03 | CDE |
| 氨甲环酸 | 湖南洞庭药业股份有限公司 | Y20250001276 | I | Exact ingredient | 2025/12/16 | CDE |
| 氨甲环酸 | 浙江竹子制药有限公司 | Y20250000943 | I | Exact ingredient | 2025/09/18 | CDE |
| 氨甲环酸 | 安徽鼎旺医药有限公司 | Y20250000688 | I | Exact ingredient | 2025/07/15 | CDE |
| 氨甲环酸 | 四川仁安药业有限责任公司 | Y20240001282 | A | Exact ingredient | 2026/02/09 | CDE |
| 氨甲环酸 | SHILPA PHARMA LIFESCIENCES LIMITED 100% EOU | Y20230000616 | I | Exact ingredient | 2023/09/12 | CDE |
| 氨甲环酸 | Ami lifesciences Pvt. Ltd. | Y20210000315 | A | Exact ingredient | 2026/09/06 | CDE |
| 氨甲环酸 | 湖南赛隆药业有限公司 | Y20210000177 | A | Exact ingredient | 2026/05/08 | CDE |
| 氨甲环酸 | DAIICHI SANKYO CO.,LTD. | Y20190009106 | A | Exact ingredient | — | CDE |
| 氨甲环酸 | 西安力邦制药有限公司 | Y20190008931 | A | Exact ingredient | 2024/01/31 | CDE |
| 氨甲环酸 | 江苏联环药业股份有限公司 | Y20190006868 | A | Exact ingredient | 2023/03/24 | CDE |
| 氨甲环酸 | 湖北中佳合成制药股份有限公司 | Y20190006325 | A | Exact ingredient | 2026/04/15 | CDE |
| 氨甲环酸 | 常州寅盛药业有限公司 | Y20190006181 | A | Exact ingredient | 2025/12/23 | CDE |
| 氨甲环酸 | 开封制药（集团）有限公司 | Y20190004445 | A | Exact ingredient | 2024/09/11 | CDE |
| 氨甲环酸 | 华润双鹤药业股份有限公司 | Y20190003756 | A | Exact ingredient | — | CDE |
| 氨甲环酸 | 湖南洞庭药业股份有限公司 | Y20190002895 | A | Exact ingredient | 2025/03/04 | CDE |
| 氨甲环酸 | 扬子江药业集团江苏海慈生物药业有限公司 | Y20190002704 | A | Exact ingredient | — | CDE |
| 氨甲环酸 | 海南葫芦娃药业集团股份有限公司 | Y20190002448 | A | Exact ingredient | 2024/07/16 | CDE |
| 氨甲环酸 | 上海现代哈森（商丘）药业有限公司 | Y20190001677 | A | Exact ingredient | 2025/03/12 | CDE |
| 氨甲环酸 | 烟台万润药业有限公司 | Y20170000447 | A | Exact ingredient | 2024/01/12 | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/10 07:23. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
-
2026/09/23Accepted
湖南赛隆药业有限公司;湖南赛隆药业（长沙）有限公司
CYHB2601801
Fact date: 2026/09/23 · Site observation date: 2026/10/22
View source ↗ -
2026/09/17Accepted
-
2026/09/17Accepted
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/10 07:27
- Chemical-drug catalogue
- Last successful update: 2026/11/10 07:23
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/10 07:25
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31
First index-page publication dates: 2026-10-26 to 2026-11-10; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/10 08:10 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 3/30; discovered pending details: 20. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Tranexamic Acid Injection
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Yearly
US$1,920
Billed every year
US$160 per month
Online subscriptions are not enabled. The form below registers interest; it does not charge or activate access.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
US$490
One payment · 12 months of access
Online comparison-table purchase is not enabled.
Billed by Creem, our merchant of record · Terms · Refund policy